ScholarWorks@Hanyang University: Ramakrishna, Suresh

Detailed Information

Ramakrishna, Suresh (Ramakrishna Suresh)

GRADUATE SCHOOL OF BIOMEDICAL SCIENCE AND ENGINEERING (DEPARTMENT OF BIOMEDICAL SCIENCE)

Research Area: 생명공학, 분자생물학

Tel 02-2220-2424
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Corrosion:7||Ubiquitination:6||Biocompatibility:5||DUB inhibitors:5||Therapeutics:4||Proteolysis:4||CRISPR:4||Cas9:3||Ubiquitin:3||Apoptosis:3||Protein degradation:3||Transcription activatorlike effector nucleases:3||posttranslational modifications:3||DNA damage:3||Antibacterial:3||Deubiquitination:3||CRISPRCas9:2||brain somatic mutation:2||Gene therapy:2||Genome editing:2||Proteasomal degradation:2||Cellular reprogramming:2||deubiquitinase:2||Drug resistance:2||proteolysis:2||deubiquitinating enzymes:2||deubiquitination:2||CRISPR/Cas9:2||EIS:2||ROS:2||Embryonic stem cells:2||DUBs:2||Delivery methods:2||ubiquitinproteasome system:2||Cancer:2||gene knockout:2||Ubiquitin proteasome system:2||BN nanosheets:2||Ubiquitinspecific protease:2||Deubiquitinating enzymes:2||Wound healing:2||Pluripotency:2||Yamanaka factors:2||Polypyrrole:2||Cell proliferation:2||Posttranslational modifications:2||liver cancer:2||Zinc finger nucleases:2||Induced pluripotent stem cells:2||apoptosis:2||Coatings:2||Stem cells:2||Deubiquitinase:1||Deubiquitinating enzyme:1||Dialysis:1||Differentiation:1||Direct conversion:1||Disease modeling:1||Disease models:1||Dose response:1||Drug carrier:1||Drug delivery:1||Drug transportcargo:1||E3 ligases:1||Electrochemical deposition:1||Enrichment:1||Epithelialmesenchymal transition:1||Etoposide:1||Exosomes:1||Fanconi anemia pathway:1||Farm animals:1||Fatty acids:1||Flow cytometry:1||Gene defect:1||Gene delivery system:1||Gene modification:1||Gonocytes:1||Guide RNA:1||HDR:1||HLA:1||HSCs:1||HeLa cells:1||Hematopoietic stem cells:1||Hereditary tyrosinemia:1||Homeostasis:1||Homologydirected repair (HDR):1||Human tumor tissues:1||Hygromycin B:1||Hyperphenylalaninemia:1||IPF:1||IRES peptideconjugation:1||Immunotherapy:1||In vitro bioactivity:1||In vitro sgRNA synthesis:1||In vivo drug delivery:1||In vivo gene correction:1||Inhibitors:1||Knockout:1||Knockout cell lines:1||Knockout cells:1||Let7:1||Leukemia:1||MG63 osteoblast cell:1||MTOR:1||Macrophages:1||Magnetic separation:1||Male infertility:1||Metabolic activity:1||Metabolic disorders:1||Metabolic engineering:1||Metastasis:1||MiRNAs:1||Microbial cell factories:1||Microfluidics:1||Microhomologymediated endjoining (MMEJ):1||Microneedles:1||Molecular docking:1||Monogenic disorder:1||Monoubiquitination:1||Mouse xenograft:1||Multi drug resistance:1||Mutant cells:1||NHEJ:1||NODlike receptor:1||Nano Nb2O5:1||Nanocomposite:1||Nanocomposites:1||Neurological disorders:1||Neuronal tumors:1||Nonviral gene vectors:1||Nuclear foci:1||Nucleic acid nanoparticles:1||Nucleosome:1||Offtarget efficiency:1||Ontarget efficiency:1||Oncogene:1||Oncogenic transformation:1||Oogenesis:1||Otubain protease:1||PEDOT:1||PEDOT coatings:1||Parkinson's disease:1||Pectin:1||Polypyrrole coatings:1||Posttranslational modification:1||Preclinical trials:1||Precision:1||Prognostic marker:1||Programmable nucleases:1||Prostate cancer:1||Prostate development:1||Proteasome:1||Protein delivery:1||Protein destabilization:1||Protein induced pluripotent stem cells:1||Protein stabilization:1||Protein turnover:1||Protein ubiquitination:1||RAinduced differentiation:1||RIGIlike receptor:1||RanBPM:1||Reduced offtarget effects:1||Regenerative medicine:1||Reprogramming:1||Respiratory disease:1||Robotics:1||SBF:1||Selfrenewal:1||Sequence specificity:1||Serratia marcescens:1||Silver nanoparticles:1||Single cell clones:1||Smallmolecule inhibitor:1||Spermatogenesis:1||Spermiogenesis:1||Superoxide:1||T7E1 assay:1||TSC1:1||TSC2:1||Targeted genetic modifications:1||Targeted sequence substitution (TSS):1||Tetrahydrobiopterin:1||Therapeutic applications:1||Ti alloys:1||Ti implants:1||Tialloy:1||Tolllike receptor:1||Triple negative breast cancer:1||Tumor growth:1||Tumor necrosis factorrelated apoptosisinducing ligand:1||Tumor nodule:1||Tumor recurrence:1||Tumor suppressor:1||UAF1:1||USP11:1||USP7:1||USPs phylogenetic tree:1||Ubiquitinproteasome system:1||Ubiquitinspecific proteases:1||Ultraviolet rays:1||YM155:1||Yeast:1||ZFN architecture:1||ZFN delivery:1||ZFN modification:1||and FADDlike apoptosis regulator:1||aurora kinase:1||autoregulation:1||brain mosaicism:1||cFLIP:1||cancer:1||cancer stem cells:1||cancer therapy:1||cell cycle:1||cell differentiation:1||chemotherapy:1||clinical tumor samples:1||colorectal carcinoma:1||death receptor 5:1||deubiquitinating enzyme:1||deubiquitinating enzyme inhibitors:1||deubiquitylating DUBs:1||direct reprogramming:1||doxorubicin:1||drug discovery:1||drug resistance:1||embryonic carcinoma cells:1||endogenous transactivation:1||enzyme assay:1||epilepsy:1||erythroid:1||focal cortical dysplasia:1||focal malformations of cortical development:1||gene editing:1||gene regulation:1||hPSC:1||hyperphenylalaninemia:1||iPSCs:1||immunotherapy:1||in silico analysis:1||infection:1||inhibitors:1||innate immunity:1||intractable epilepsy:1||kinase inhibitor:1||leukemia:1||lymphoma:1||macrophages:1||microflora:1||mitotic regulator:1||mouse models:1||multidrug resistance:1||myeloid:1||nanomedicines:1||neural stem cells:1||neurological damage:1||oncogenesis:1||oncogenic transformation:1||oxidative stress:1||pathogens:1||phage:1||primary cilia:1||proteasome degradation:1||protein quality control:1||protein stabilization:1||selfdeubiquitylation:1||signaling:1||signaling pathways:1||ssODN:1||stemness:1||stimuliresponsive degradation:1||survivin:1||tetrahydrobiopterin:1||tumor model:1||tumor necrosis factorrelated apoptosis inducing ligand therapy:1||ubiquitin:1||ubiquitin proteasome system:1||ubiquitin specific protease:1||ubiquitination:1||ubiquitylation:1||26S proteasome:1||vitamins:1||316L SS:1||AFM:1||AXL receptor tyrosine kinase:1||Acrosome:1||Alzheimer's disease:1||Anti tumor:1||Antitumor activity:1||Anticancer drugs:1||Anticancer therapy:1||Antioxidants:1||ApoptosisBioconjugatesCD44DUB enzymeHyaluronanTumor:1||Apoptotic signal:1||Biofilm inhibition:1||Biofuels:1||Biomaterials:1||CAR T:1||CARNs:1||CASP8:1||CRISPR delivery:1||CRISPRCas:1||CRISPRCas9 genome editing:1||CRISPRCas9 system:1||CRISPR/Cas9 applications:1||Cancer cell proliferation:1||Cancer progression:1||Cancer stem cells:1||Cas9 conjugation:1||Cas9 knockout:1||Cas9 protein purification:1||CeO2 NPs:1||Cell apoptosis:1||Cell death:1||Cell migration:1||Cell survival:1||Cell viability:1||Cervical cancer:1||Chitosan:1||Chromosomal breakage:1||Chromosomal inversion:1||Clinical histology:1||Clustered regularly interspaced short palindrome repeat associated system:1||Clustered regularly interspaced short palindromic repeats:1||Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPRassociated system:1||Colon cancer:1||Conducting polymers:1||Cytokineinducible:1||DNA repair:1||DR5:1||DUB inhibitor:1||Dead Cas9:1||Destabilization:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE